Xing-Yue Chen, Jun Chen, Kun-Lan Long, Peng Ding, Rong Li, Li-Jia Zhi
{"title":"Case report: Bullous pemphigoid combined with Sjögren’s syndrome complicated by central nervous system infection","authors":"Xing-Yue Chen, Jun Chen, Kun-Lan Long, Peng Ding, Rong Li, Li-Jia Zhi","doi":"10.3389/fimmu.2024.1419054","DOIUrl":null,"url":null,"abstract":"BackgroundBullous pemphigoid (BP) is the most common autoimmune blistering skin disease in humans, characterized by tense blisters, erosions, urticarial lesions, and itching on normal or erythematous skin. Many autoimmune diseases are considered comorbidities of BP, but clinical case reports of BP complicated by Sjögren’s syndrome are very scarce. Furthermore, cases of central nervous system infection secondary to both autoimmune diseases are even rarer.Case presentationWe report a 74-year-old woman diagnosed with bullous pemphigoid, who showed relief of active lesions after treatment with methylprednisolone and dupilumab injections. However, she was admitted for pulmonary infection during which she was diagnosed with Sjögren’s syndrome (SS). Subsequently, the patient developed altered consciousness, indicating a central nervous system infection. Adjustment of steroid dosage and aggressive antimicrobial therapy led to alleviation of symptoms.ConclusionThe coexistence of autoimmune subepidermal blistering diseases and SS is rare. The role of SS in the pathogenesis of skin lesions is unclear, and the relationship between these blistering diseases and SS remains elusive. Further research is needed to determine whether there are common pathological mechanisms between the two conditions.","PeriodicalId":5,"journal":{"name":"ACS Applied Materials & Interfaces","volume":null,"pages":null},"PeriodicalIF":8.3000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Materials & Interfaces","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fimmu.2024.1419054","RegionNum":2,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MATERIALS SCIENCE, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
BackgroundBullous pemphigoid (BP) is the most common autoimmune blistering skin disease in humans, characterized by tense blisters, erosions, urticarial lesions, and itching on normal or erythematous skin. Many autoimmune diseases are considered comorbidities of BP, but clinical case reports of BP complicated by Sjögren’s syndrome are very scarce. Furthermore, cases of central nervous system infection secondary to both autoimmune diseases are even rarer.Case presentationWe report a 74-year-old woman diagnosed with bullous pemphigoid, who showed relief of active lesions after treatment with methylprednisolone and dupilumab injections. However, she was admitted for pulmonary infection during which she was diagnosed with Sjögren’s syndrome (SS). Subsequently, the patient developed altered consciousness, indicating a central nervous system infection. Adjustment of steroid dosage and aggressive antimicrobial therapy led to alleviation of symptoms.ConclusionThe coexistence of autoimmune subepidermal blistering diseases and SS is rare. The role of SS in the pathogenesis of skin lesions is unclear, and the relationship between these blistering diseases and SS remains elusive. Further research is needed to determine whether there are common pathological mechanisms between the two conditions.
背景大疱性类天疱疮(Bullous pemphigoid,BP)是人类最常见的自身免疫性大疱性皮肤病,其特点是在正常皮肤或红斑皮肤上出现张力性水疱、糜烂、荨麻疹皮损和瘙痒。许多自身免疫性疾病都被认为是 BP 的合并症,但 BP 并发斯约格伦综合征的临床病例报告却非常罕见。我们报告了一名被诊断为大疱性类天疱疮的 74 岁女性患者,她在接受甲基强的松龙和杜比单抗注射治疗后,活动性皮损有所缓解。然而,她因肺部感染入院,期间被诊断出患有斯约格伦综合征(SS)。随后,患者出现了意识改变,表明中枢神经系统受到感染。调整类固醇剂量和积极抗菌治疗后,症状有所缓解。SS在皮肤病变发病机制中的作用尚不清楚,这些水疱病与SS之间的关系也仍然难以捉摸。要确定这两种疾病之间是否存在共同的病理机制,还需要进一步的研究。
期刊介绍:
ACS Applied Materials & Interfaces is a leading interdisciplinary journal that brings together chemists, engineers, physicists, and biologists to explore the development and utilization of newly-discovered materials and interfacial processes for specific applications. Our journal has experienced remarkable growth since its establishment in 2009, both in terms of the number of articles published and the impact of the research showcased. We are proud to foster a truly global community, with the majority of published articles originating from outside the United States, reflecting the rapid growth of applied research worldwide.